Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives

References

• Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Therapeut. 2012;2(2):113.
   Google Scholar
• Frankovich J, Thienemann M, Pearlstein J, Crable A, Brown K, Chang K. Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients. J Child Adolesc Psychopharmacol. 2015;25(1):38–47.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association; DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC, USA: American Psychiatric Association; 2013:947.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. TR. ^TM. Update. Washington, DC: American psychiatric association; 2022. Available from. https://www.psychiatry.org/getmedia/34c43e15-2618-4d2b-9f67-6bef5c40f75a/APA-DSM5TR-Update-September-2022.pdf. Accessed September 20 2022.
   Google Scholar
• ICD-11. International Classification of Diseases 11th Revision. The global standard for diagnostic health information. Available from: who.int. Accessed May 3, 2023.
   Google Scholar
• Swedo SE, Seidlitz J, Kovacevic M, et al. Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings. J Child Adolesc Psychopharmacol. 2015;25(1):26–30.
   PubMed Web of Science ®Google Scholar
• Gromark C, Harris RA, Wickstrom R, et al. Establishing a pediatric acute-onset neuropsychiatric syndrome clinic: baseline clinical features of the pediatric acute-onset neuropsychiatric syndrome cohort at Karolinska Institutet. J Child Adolesc Psychopharmacol. 2019;29(8):625–633.
   PubMed Web of Science ®Google Scholar
• Hesselmark E, Bejerot S. Clinical features of paediatric acute-onset neuropsychiatric syndrome: findings from a case- control study. BJPsych Open. 2019;5(2):e25.
   PubMed Web of Science ®Google Scholar
• Johnson M, Fernell E, Preda I, et al. Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort study. Lancet Child Adolesc Health. 2019;3(3):175–180.
   PubMedGoogle Scholar
• Gagliano A, Galati C, Ingrassia M, et al. Pediatric acute-onset neuropsychiatric syndrome: a data mining approach to a very specific constellation of clinical variables. J Child Adolesc Psychopharmacol. 2020;30(8):495–511.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264–271.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154(1):110–112.
   PubMed Web of Science ®Google Scholar
• Calaprice D, Tona J, Parker-Athill EC, Murphy TK. A survey of pediatric acute-onset neuropsychiatric syndrome characteristics and course. J Child Adolesc Psychopharmacol. 2017;27(7):607–618.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004;113(4):907–911.
   PubMed Web of Science ®Google Scholar
• Chang K, Frankovich J, Cooperstock M, et al. Clinical evaluation of youth with paediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2015;25(1):3–13.
   PubMed Web of Science ®Google Scholar
• PANDAS: Diagnosis and Treatment. Oklahoma City: Moleculera; 2016. Available from https://www.moleculeralabs.com/pandas-diagnosis/andtreatment/. Accessed November 20, 2022.
   Google Scholar
• Swedo SE, Frankovich J, Murphy TK. Overview of treatment of pediatric acute-onset neuropsychiatric syndrome. J Child Adolesc Psychopharmacol. 2017;27(7):562–565.
   PubMed Web of Science ®Google Scholar
• Gamucci A, Uccella S, Sciarretta L, et al. PANDAS and PANS: clinical, neuropsychological, and biological characterization of a monocentric series of patients and proposal for a diagnostic protocol. J Child Adolesc Psychopharmacol. 2019;29(4):305–312.
   PubMed Web of Science ®Google Scholar
• Rea I, Guido CA, Spalice A. Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study. Front Neurol. 2021;12:741176.
   PubMed Web of Science ®Google Scholar
• Williams KA, Swedo SE. Post-infectious autoimmune disorders: Sydenham’s chorea, PANDAS and beyond. Brain Res. 2015;1617:144–154.
   PubMed Web of Science ®Google Scholar
• Goncalves MVM, Harger R, Braatz V, et al. Pediatric acute-onset neuropsychiatric syndrome (PANS) misdiagnosed as autism spectrum disorder. Immunol Lett. 2018;203:52–53.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu RJ, Fahey S, et al. Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity. Am J Psychiatry. 2021;178(1):48–64.
   PubMed Web of Science ®Google Scholar
• Wilbur C, Bitnun A, Kronenberg S, et al. PANDAS/PANS in childhood: Controversies and evidence. Paediatr Child Health. 2019;24(2):85–91.
   PubMed Web of Science ®Google Scholar
• Orlovska S, Vestergaard CH, Bech BH, Nordentoft M, Vestergaard M, Benros ME. Association of streptococcal throat infection with mental disorders: testing key aspects of the PANDAS hypothesis in a nationwide study. JAMA Psychiatry. 2017;74(7):740–746.
   PubMed Web of Science ®Google Scholar
• Wang HC, Lau CI, Lin CC, Chang A, Kao CH. Group A streptococcal infections are associated with increased risk of pediatric neuropsychiatric disorders: a Taiwanese population-based cohort study. J Clin Psychiatry. 2016;77(7):e848–e854.
   PubMed Web of Science ®Google Scholar
• Jaspers-Fayer F, Han SHJ, Chan E, et al. Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2017;27(4):332–341.
   PubMed Web of Science ®Google Scholar
• Jyonouchi H, Geng L. Whole-exome sequencing in a subject with fluctuating neuropsychiatric symptoms, immunoglobulin G1 deficiency, and subsequent development of Crohn’s disease: a case report. J Med Case Rep. 2022;16(1):187.
   PubMedGoogle Scholar
• Kaneko A, Kaneko J, Tominaga N, et al. Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis. J Neurol. 2018;265(3):586–596.
   PubMed Web of Science ®Google Scholar
• Clish CB. Metabolomics: an emerging but powerful tool for precision medicine. Cold Spring Harb Mol Case Stud. 2015;1(1):a000588.
   PubMed Web of Science ®Google Scholar
• Murgia F, Gagliano A, Tanca MG, et al. Metabolomic characterization of pediatric acute-onset neuropsychiatric syndrome (PANS). Front Neurosci. 2021;28(15):645267.
   Google Scholar
• Gagliano A, Murgia F, Capodiferro AM, et al. 1H-NMR-based metabolomics in autism spectrum disorder and pediatric acute-onset neuropsychiatric syndrome. J Clin Med. 2022;11(21):6493.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Patel PD, McGuire JF, et al. Characterization of the paediatric acute-onset neuropsychiatric syndrome phenotype. J Child Adolesc Psychopharmacol. 2015;25(1):14–25.
   PubMed Web of Science ®Google Scholar
• Frankovich J, Swedo S, Murphy T, et al. Clinical management of pediatric acute onset neuropsychiatric syndrome: part II—use of immunomodulatory therapies. J Child Adolesc Psychopharmacol. 2017;27(7):574–593.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Storch EA, Lewin AB, Edge PJ, Goodman WK. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012;160(2):314–319.
   PubMed Web of Science ®Google Scholar
• Pavone P, Parano E, Battaglia C, et al. Severe psychotic symptoms in youth with PANS/PANDAS: case-series. J Child Adolesc Psychopharmacol. 2020;30(9):567–571.
   PubMed Web of Science ®Google Scholar
• Silverman M, Frankovich J, Nguyen E, et al. Psychotic symptoms in youth with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) may reflect syndrome severity and heterogeneity. J Psychiatr Res. 2019;110:93–102.
   PubMed Web of Science ®Google Scholar
• Pon NC, Houck KM, Muscal E, Idicula SA. Voltage-gated potassium channel antibody autoimmune encephalopathy presenting with isolated psychosis in an adolescent. J Psychiatr Pract. 2017;23(6):441–445.
   PubMed Web of Science ®Google Scholar
• Ioghen MR, Epure DA, Teleanu RI. Pediatric autoimmune encephalitis: practical aspects. Maedica. 2020;15(4):517–520.
   PubMedGoogle Scholar
• Cellucci T, Van Mater H, Graus F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm. 2020;7(2):e663.
   PubMed Web of Science ®Google Scholar
• van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hoogenraad CC, Sillevis Smitt PA. Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system. Autoimmun Rev. 2014;13(3):299–312.
   PubMed Web of Science ®Google Scholar
• Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018;378(9):840–851.
   PubMed Web of Science ®Google Scholar
• Platt MP, Agalliu D, Cutforth T. Hello from the other side: how autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis. Front Immunol. 2017;8:442.
   PubMed Web of Science ®Google Scholar
• Mader S, Brimberg L, Diamond B. The role of brain-reactive autoantibodies in brain pathology and cognitive impairment. Front Immunol. 2017;8:1101.
   PubMed Web of Science ®Google Scholar
• Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338(1):94–114.
   PubMedGoogle Scholar
• Cutforth T, DeMille MM, Agalliu I, Agalliu D. CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors. Future Neurol. 2016;11(1):63–76.
   PubMedGoogle Scholar
• Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol. 2006;179(1–2):173–179.
   PubMed Web of Science ®Google Scholar
• Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(Pt 11):3453–3468.
   PubMedGoogle Scholar
• Grant JE. Clinical practice: obsessive-compulsive disorder. N Engl J Med. 2014;371(7):646–653.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Ozawa T. Neural circuits in goal-directed and habitual behavior: Implications for circuit dysfunction in obsessive-compulsive disorder. Neurochem Int. 2019;129:104464.
   PubMed Web of Science ®Google Scholar
• Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358–1367.
   PubMed Web of Science ®Google Scholar
• Stein DJ, Costa D, Lochner C, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5(1):52.
   PubMedGoogle Scholar
• Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep. 2019;21(8):78.
   PubMed Web of Science ®Google Scholar
• Lamothe H, Baleyte JM, Smith P, Pelissolo A, Mallet L. Individualized immunological data for precise classification of OCD patients. Brain Sci. 2018;8(8):149.
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Frans E, Pérez-Vigil A, et al. A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette’s/chronic tic disorders. Mol Psychiatry. 2018;23(7):1652–1658.
   PubMed Web of Science ®Google Scholar
• Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235–246.
   PubMed Web of Science ®Google Scholar
• Foroughipour M, Behdani F, Hebrani P, Marvast MN, Esmatinia F. Akhavanre- zayat A. Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: a cross-sectional study. J Res Med Sci. 2012;17(3):248–253.
   PubMed Web of Science ®Google Scholar
• Pérez-Vigil A, Fernández de la Cruz L, Brander G, Isomura K, Gromark C, Mataix- CD. The link between autoimmune diseases and obsessive-compulsive and tic disorders: a systematic review. Neurosci Biobehav Rev. 2016;71:542–562.
   PubMed Web of Science ®Google Scholar
• Cosco TD, Pillinger T, Emam H, et al. Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol. 2019;56(7):4751–4759.
   PubMed Web of Science ®Google Scholar
• Tamouza R, Krishnamoorthy R, Leboyer M. Understanding the genetic con- tribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain Behav Immun. 2021;91:731–739.
   PubMed Web of Science ®Google Scholar
• Costas J, Carrera N, Alonso P, et al. Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia. Transl Psychiatry. 2016;6(3):e768.
   PubMedGoogle Scholar
• Rodriguez N, Morer A, González-Navarro EA, et al. Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder. World J Biol Psychiatry. 2019;20(5):352–358.
   PubMed Web of Science ®Google Scholar
• Noble JA. Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun. 2015;64:101–112.
   PubMed Web of Science ®Google Scholar
• Hyman SE. PANDAS: too narrow a view of the neuroimmune landscape. Am J Psychiatry. 2021;178(1):5–7.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Baldwin D, Abelli M, et al. Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry. 2016;17(5):321–365.
   PubMed Web of Science ®Google Scholar
• Endres D, Pollak TA, Bechter K, et al. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype. Transl Psychiatry. 2022;12(1):5.
   PubMed Web of Science ®Google Scholar
• Bechter K. The challenge of assessing mild neuroinflammation in severe mental disorders. Front Psychiatry. 2020;11:773.
   PubMed Web of Science ®Google Scholar
• Lepri G, Rigante D, Bellando Randone S, et al. Clinical-serological characterization and treatment outcome of a large cohort of Italian children with pediatric autoimmune neuropsychiatric disorder associated with Streptococcal infection and pediatric acute neuropsychiatric syndrome. J Child Adolesc Psychopharmacol. 2019;29(8):608–614.
   PubMed Web of Science ®Google Scholar
• Frick LR, Rapanelli M, Jindachomthong K, et al. Differential binding of antibodies in PANDAS patients to cholinergic inter- neurons in the striatum. Brain Behav Immun. 2018;69:304–311.
   PubMed Web of Science ®Google Scholar
• Brimberg L, Benhar I, Mascaro-Blanco A, et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology. 2012;37(9):2076–2087.
   PubMed Web of Science ®Google Scholar
• Bauer J, Bien CG. Neuropathology of autoimmune encephalitides. Handb Clin Neurol. 2016;133:107–120.
   PubMedGoogle Scholar
• Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311–336.
   PubMed Web of Science ®Google Scholar
• Dileepan T, Smith ED, Knowland D, et al. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest. 2016;126(1):303–317.
   PubMed Web of Science ®Google Scholar
• Platt MP, Bolding KA, Wayne CR, et al. Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of post- infectious autoimmune encephalitis. Proc Natl Acad Sci USA. 2020;117(12):6708–6716.
   PubMed Web of Science ®Google Scholar
• Jones BE, Tovar KR, Goehring A, et al. Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors. Sci Transl Med. 2019;11(500):eaaw0044.
   PubMed Web of Science ®Google Scholar
• Steardo L, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry. 2020;10(1):261.
   PubMed Web of Science ®Google Scholar
• Tang SW, Helmeste D, Leonard B. Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation. Acta Neuropsychiatrica. 2021;33(4):165–177.
   PubMed Web of Science ®Google Scholar
• Pavone P, Ceccarelli M, Marino S, et al. SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome. Lancet Child Adolesc Health. 2021;5(6):e19–e21.
   PubMedGoogle Scholar
• Chain JL, Alvarez K, Mascaro-Blanco A, et al. Autoantibody biomarkers for basal ganglia encephalitis in Sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with Strepto- coccal infections. Front Psychiatry. 2020;11:564.
   PubMed Web of Science ®Google Scholar
• Shimasaki C, Frye RE, Trifiletti R, et al. Evaluation of the Cunningham PanelTM in pediatric autoimmune neuropsychia- tric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): changes in antineuronal antibody titers parallel changes in patient symptoms. J Neuroimmunol. 2020;339:577138.
   PubMed Web of Science ®Google Scholar
• Connery K, Tippett M, Delhey LM, et al. Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism. Transl Psychiatry. 2018;8(1):148.
   PubMedGoogle Scholar
• Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839–887.
   PubMed Web of Science ®Google Scholar
• Hesselmark E, Bejerot S. Biomarkers for diagnosis of Pediatric Acute Neuropsychiatric Syndrome (PANS) - sensitivity and specificity of the Cunningham Panel. J Neuroimmunol. 2017;312:31–37.
   PubMed Web of Science ®Google Scholar
• Bejerot S, Hesselmark E. The Cunningham Panel is an unreliable biological measure. Transl Psychiatry. 2019;9(1):49.
   PubMedGoogle Scholar
• Lennox BR, Palmer-Cooper EC, Pollak T, et al. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. Lancet Psychiatry. 2017;4(1):42–48.
   PubMed Web of Science ®Google Scholar
• Pollak TA, Lennox BR, Müller S, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93–108.
   PubMed Web of Science ®Google Scholar
• Pearlman DM, Vora HS, Marquis BG, Najjar S, Dudley LA. Anti-basal ganglia antibodies in primary obsessive-compulsive disorder: systematic review and meta-analysis. Br J Psychiatry. 2014;205(1):8–16.
   PubMed Web of Science ®Google Scholar
• Cox CJ, Zuccolo AJ, Edwards EV, et al. Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2015;25(1):76–85.
   PubMed Web of Science ®Google Scholar
• Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 2000;157(2):281–283.
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae. Microbiol Spectr. 2019;7(4). doi:10.1128/microbiolspec.GPP3-0045-2018
   PubMed Web of Science ®Google Scholar
• Sigra S, Hesselmark E, Bejerot S. Treatment of PANDAS and PANS: a systematic review. Neurosci Biobehav Rev. 2018;86:51–65.
   PubMed Web of Science ®Google Scholar
• Full Text View - ClinicalTrials.gov. Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement. Available from: https://clinicaltrials.gov/ct2/show/NCT04323566. Accessed November 18, 2022.
   Google Scholar
• Pohlman D, PANDAS Network: PN 2018 State of Our Children SURVEY. Downloaded by East Carolina University. Available from: http://pandasnetwork.org/wp-16. Accessed September 16, 2019.
   Google Scholar
• Westwell-Roper C, Williams KA, Samuels J, et al. Immune-related comorbidities in childhood-onset obsessive compulsive disorder: lifetime prevalence in the obsessive compulsive disorder collaborative genetics association study. J Child Adolesc Psychopharmacol. 2019;29:615–624.
   PubMed Web of Science ®Google Scholar
• Chan A, Phu T, Farhadian B, Willett T, Thienemann M, Frankovich J. Familial clustering of immune-mediated diseases in children with abrupt-onset obsessive compulsive disorder. J Child Adolesc Psychopharmacol. 2020;30(5):345–346.
   PubMed Web of Science ®Google Scholar
• Trifiletti R, Lachman HM, Manusama O, et al. Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing. Sci Rep. 2022;12(1):11106.
   PubMedGoogle Scholar
• Leblond CS, Nava C, Polge A, et al. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genet. 2014;10(9):e1004580.
   PubMed Web of Science ®Google Scholar
• Lombardo MV, Moon HM, Su J, Palmer TD, Courchesne E, Pramparo T. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder. Mol Psychiatry. 2018;23(4):1001–1013.
   PubMed Web of Science ®Google Scholar
• Jones HF, Han VX, Patel S, et al. Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: transcriptomic data show common enriched innate immune pathways. Brain Behav Immun. 2021;94:308–317.
   PubMed Web of Science ®Google Scholar
• Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell. 2019;179(7):1469–1482.e11.
   PubMed Web of Science ®Google Scholar
• Sotgiu S, Manca S, Gagliano A, et al. Immune regulation of neurodevelopment at the mother-foetus interface: the case of autism. Clin Transl Immunol. 2020;9(11):e1211.
   PubMed Web of Science ®Google Scholar
• Lisboa BCG, Oliveira KC, Tahira AC, et al. Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysis. Sci Rep. 2019;9:3086.
   PubMed Web of Science ®Google Scholar
• Martino D, Johnson I, Leckman JF. What Does Immunology Have to Do With Normal Brain Development and the Pathophysiology Underlying Tourette Syndrome and Related Neuropsychiatric Disorders? Front Neurol. 2020;11:567407.
   PubMed Web of Science ®Google Scholar
• Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. Science. 2016;353(6301):772–777.
   PubMed Web of Science ®Google Scholar
• Chang, Kiki, et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. Journal of Child and Adolescent Psychopharmacology. 2015;25(1):3–13.
   PubMed Web of Science ®Google Scholar
• Mahony T, Sidell D, Gans H, et al. Palatal petechiae in the absence of group a streptococcus in pediatric patients with acute-onset neuropsychiatric deterioration: a cohort study. J Child Adolesc Psychopharmacol. 2017;27(7):660–666.
   PubMed Web of Science ®Google Scholar
• Miyazaki C, Koyama M, Ota E, et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):120.
   PubMedGoogle Scholar
• Frankovich J, Thienemann M, Rana S, Chang K. Five youth with pediatric acute-onset neuropsychiatric syndrome of differing etiologies. J Child Adolesc Psychopharmacol. 2015;25(1):31–37.
   PubMed Web of Science ®Google Scholar
• Rosa JS, Hernandez JD, Sherr JA, et al. Allergic diseases and immune-mediated food disorders in pediatric acute-onset neuropsychiatric syndrome. Pediatr Allergy Immunol Pulmonol. 2018;31(3):158–165.
   PubMed Web of Science ®Google Scholar
• Chan A, Gao J, Houston M, et al. Children With PANS May Manifest POTS. Front Neurol. 2022;13:819636.
   PubMed Web of Science ®Google Scholar
• Vaquerizo-Serrano J, Salazar De Pablo G, Singh J, Santosh P. Catatonia in autism spectrum disorders: a systematic review and meta-analysis. Eur Psychiatry. 2021;65(1):e4.
   PubMed Web of Science ®Google Scholar
• Elia J, Dell ML, Friedman DF, et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1145–1150.
   PubMed Web of Science ®Google Scholar
• Schlansky K, Facer B, Tanguturi YC, Cundiff AW, Fuchs DC. Pediatric Acute-Onset Neuropsychiatric Syndrome and Catatonia: A Case Report. Psychosomatics. 2020;61(1):86–91.
   PubMed Web of Science ®Google Scholar
• Prosell U, Norman H, Sand A, McAllister A. Infection and speech: Disfluency and other speech symptoms in Pediatric Acute-onset Neuropsychiatric Syndrome. J Commun Disord. 2022;99:106250.
   PubMed Web of Science ®Google Scholar
• Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30(2):107–110.
   PubMed Web of Science ®Google Scholar
• Williams KA, Swedo SE, Farmer CA, et al. Randomized, controlled trial of intravenous immunoglobulin for paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Am Acad Child Adoles Psychiatry. 2016;55:860–7.e2.
   PubMedGoogle Scholar
• Kumar A, Williams MT, Chugani HT. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and Tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol. 2015;30(6):749–756.
   PubMed Web of Science ®Google Scholar
• Zheng J, Frankovich J, McKenna ES, et al. Association of pediatric acute-onset neuropsychiatric syndrome with microstructural differences in brain regions detected via diffusion-weighted magnetic resonance imaging. JAMA Netw Open. 2020;3(5):e204063.
   PubMed Web of Science ®Google Scholar
• Gagliano A, Puligheddu M, Ronzano N, et al. Artificial Neural Networks Analysis of polysomnographic and clinical features in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): from sleep alteration to “Brain Fog”. Nat Sci Sleep. 2021;13:1209–1224.
   PubMed Web of Science ®Google Scholar
• Santoro JD, Frankovich J, Bhargava S. Continued presence of period limb movements during REM sleep in patients with chronic static Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). J Clin Sleep Med. 2018;14(7):1187–1192.
   PubMed Web of Science ®Google Scholar
• Gaughan T, Buckley A, Hommer R, et al. Rapid eye movement sleep abnormalities in children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). J Clin Sleep Med. 2016;12(7):1027–1032.
   PubMed Web of Science ®Google Scholar
• Pfeiffer HCV, De Visscher C, Gjone IH, et al. Authors’ reply regarding “On diagnosing and treating PANS/PANDAS: Questions from a patient support group”. Acta Paediatr. 2021;110:3390–3391.
   PubMed Web of Science ®Google Scholar
• Pfeiffer HCV, Wickstrom R, Skov L, et al. Clinical guidance for diagnosis and management of suspected Pediatric Acute-onset Neuropsychiatric Syndrome in the Nordic countries. Acta Paediatr. 2021;110(12):3153–3160.
   PubMed Web of Science ®Google Scholar
• Thienemann M. Clinical management of pediatric acute-onset neuropsychiatric syndrome: part I—psychiatric and behavioral interventions. J Child Adolesc Psychopharmacol. 2017;27(7):566–573.
   PubMed Web of Science ®Google Scholar
• Thienemann M, Park M, Chan A, Frankovich J. Patients with abrupt early-onset OCD due to PANS tolerate lower doses of antidepressants and antipsychotics. J Psychiatr Res. 2021;135:270–278.
   PubMed Web of Science ®Google Scholar
• Twilt M, Benseler SM. Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy. Rheumatology. 2014;53(8):1359–1368.
   PubMed Web of Science ®Google Scholar
• Brown KD, Farmer C, Freeman GM, et al. Effect of early and prophylactic nonsteroidal anti-inflammatory drugs on flare duration in pediatric acute-onset neuropsychiatric syndrome: an observational study of patients followed by an academic community-based pediatric acute-onset neuropsychiatric syndrome clinic. J Child Adolesc Psychopharmacol. 2017;27(7):619–628.
   PubMed Web of Science ®Google Scholar
• Calaprice D, Janice T, Murphy TK. Treatment of pediatric acute-onset neuropsychiatric disorder in a large survey population. J Child Adolesc Psychopharmacol. 2018;28(2):92–103.
   PubMed Web of Science ®Google Scholar
• Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr. 2008;75(10):1057–1066.
   PubMed Web of Science ®Google Scholar
• McMahon D, Oakden W, Hynynen K. Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure. Theranostics. 2020;10(4):1604–1618.
   PubMed Web of Science ®Google Scholar
• Barna L, Walter FR, Harazin A, et al. Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage. Fluids Barriers CNS. 2020;17:5.
   PubMed Web of Science ®Google Scholar
• Spartz EJ, Freeman GM, Brown K, Farhadian B, Thienemann M, Frankovich J. Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study. J Child Adolesc Psychopharmacol. 2017;27(7):652–659.
   PubMed Web of Science ®Google Scholar
• Westwell-Roper C, Best JR, Elbe D, et al. Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive-compulsive disorder: protocol for a single-site randomised quadruple-blind Phase II study. BMJ Open. 2022;12(1):e054296.
   PubMed Web of Science ®Google Scholar
• Norris PAA, Kaur G, Lazarus AH. New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases. Curr Opin Hematol. 2020;27:392–398.
   PubMed Web of Science ®Google Scholar
• Williams KA, Swedo SE, Farmer CA, et al. Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with Streptococcal infections. J Am Acad Child Adolesc Psychiatry. 2016;55:860–870 e2.
   PubMedGoogle Scholar
• Leibold C, Thienemann M, Farhadian B, Willett T, Frankovich J. Psychometric properties of the pediatric acute-onset neuropsychiatric syndrome global impairment score in children and adolescents with pediatric acute-onset neuropsychiatric syndrome. J Child Adolesc Psychopharmacol. 2019;29(1):41–49.
   PubMed Web of Science ®Google Scholar
• Hajjari P, Oldmark MH, Fernell E, et al. Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children. BMC Psychiatry. 2022;22(1):535.
   PubMed Web of Science ®Google Scholar
• Johnson M, Ehlers S, Fernell E, Hajjari P, Wartenberg C, Wallerstedt SM. Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): a systematic review. PLoS One. 2021;16(7):e0253844.
   PubMed Web of Science ®Google Scholar
• Latimer ME, L’Etoile N, Seidlitz J, Swedo SE. Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Child Adolesc Psychopharmacol. 2015;25(1):70–75.
   PubMed Web of Science ®Google Scholar
• Lebowitz ER, Vitulano LA, Mataix-Cols D, Leckman JF. Editorial perspective: When OCD takes over.the family! Coercive and disruptive behaviours in paediatric obsessive compulsive disorder. J Child Psychol Psychiatry. 2011;52:1249–1250.
   PubMed Web of Science ®Google Scholar
• Hezel DM, Simpson HB. Exposure and response prevention for obsessive-compulsive disorder: a review and new directions. Indian J Psychiatry. 2019;61(Suppl 1):S85–S92.
   PubMedGoogle Scholar
• Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015;17(3):337–346.
   PubMed Web of Science ®Google Scholar
• Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45(12):1564–1571.
   PubMed Web of Science ®Google Scholar
• Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood onset neuropsychiatric disorders. Biol Psychiatry. 2005;57(7):788–792.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Brennan EM, Johnco C, et al. A double-blind randomized placebo-controlled pilot study of azithromycin in youth with acute-onset obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2017;27(7):640–650.
   PubMed Web of Science ®Google Scholar
• Blankenship P, Kurek K. Azithromycin prophylaxis in an adolescent with PANDAS. J Pediatr Pharmacol Ther. 2020;25(1):61–63.
   PubMedGoogle Scholar
• Lendermon EA, Coon TA, Bednash JS, et al. Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation. Respir Res. 2017;18(1):131.
   PubMedGoogle Scholar
• Stock ML, Fiedler KJ, Acharya S, et al. Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities. Neuropharmacology. 2013;73:174–182.
   PubMed Web of Science ®Google Scholar
• Burchi E, Pallanti S. Diagnostic issues in early-onset obsessive-compulsive disorder and their treatment implications. Curr Neuropharmacol. 2019;17(8):672–680.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Mink JW, Singer HS. A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome. J Pediatr. 2018;199:243–251.
   PubMed Web of Science ®Google Scholar
• Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36(12):2452–2459.
   PubMed Web of Science ®Google Scholar
• Brown K, Farmer C, Farhadian B, Hernandez J, Thienemann M, Frankovich J. Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic. J Child Adolesc Psychopharmacol. 2017;27(7):629–639.
   PubMed Web of Science ®Google Scholar
• Farhood Z, Ong AA, Discolo CM. PANDAS: A systematic review of treatment options. Int J Pediatr Otorhinolaryngol. 2016;89:149–153.
   PubMed Web of Science ®Google Scholar
• Dale RC, Gorman MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. Curr Opin Neurol. 2017;30(3):334–344.
   PubMed Web of Science ®Google Scholar
• Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: A Natural Compound for Health Management. Int J Mol Sci. 2021;22(10):5305.
   PubMed Web of Science ®Google Scholar
• Khalaj M, Saghazadeh A, Shirazi E, et al. Palmitoylethanolamide as adjunctive therapy for autism: efficacy and safety results from a randomized controlled trial. J Psychiatr Res. 2018;103:104–111.
   PubMed Web of Science ®Google Scholar
• De Gregorio D, Manchia M, Carpiniello B, et al. Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. J Affect Disord. 2019;255:S0165-0327(18)31599–4.
   PubMed Web of Science ®Google Scholar
• Abedini T, Hosseyni R, Ghannadi F, et al. Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial. Psychiatry Clin Neurosci. 2022;76(10):505–511.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Landeros-Weisenberger A, Johnson JA, Leckman JF. A phase-2 pilot study of a therapeutic combination of Δ9-tetrahydracannabinol and palmitoylethanolamide for adults with Tourette’s syndrome. J Neuropsychiatry Clin Neurosci. 2021;33(4):328–336.
   PubMed Web of Science ®Google Scholar
• Cheng S, Hou J, Zhang C, et al. Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration. Sci Rep. 2015;5:10535.
   PubMed Web of Science ®Google Scholar
• Meyer J. Inflammation, Obsessive-Compulsive Disorder, and Related Disorders. Curr Top Behav Neurosci. 2021;49:31–53.
   PubMedGoogle Scholar
• Rosenblat JD, McIntyre RS. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials. J Affect Disord. 2018;227:219–225.
   PubMed Web of Science ®Google Scholar
• Ghaleiha A, Alikhani R, Kazemi MR, et al. Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial. J Child Adolesc Psychopharmacol. 2016;26(9):784–791.
   PubMed Web of Science ®Google Scholar
• Pardo CA, Buckley A, Thurm A, et al. A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord. 2013;5(1):9.
   PubMedGoogle Scholar
• Marazziti D, Mucci F, Fontenelle LF. Immune system and obsessive-compulsive disorder. Psychoneuroendocrinology. 2018;93:39–44.
   PubMed Web of Science ®Google Scholar
• Chiarello F, Spitoni S, Hollander E, Matucci Cerinic M, Pallanti S. An expert opinion on PANDAS/PANS: highlights and controversies. Int J Psychiatry Clin Pract. 2017;21(2):91–98.
   PubMed Web of Science ®Google Scholar
• Irani SR, Nath A, Zipp F. The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain. Brain. 2021;144(7):e59.
   PubMedGoogle Scholar
• Hsu CJ, Wong LC, Lee WT. Immunological dysfunction in Tourette syndrome and related disorders. Int J Mol Sci. 2021;22(2):853.
   PubMed Web of Science ®Google Scholar
• Morris CM, Pardo-Villamizar C, Gause CD, Singer HS. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci. 2009;276:45–48.
   PubMed Web of Science ®Google Scholar
• Stagi S, Rigante D, Lepri G, Bertini F, Matucci-Cerinic M, Falcini F. Evaluation of autoimmune phenomena in patients with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Autoimmun Rev. 2014;13:1236–1240.
   PubMed Web of Science ®Google Scholar
• Stagi S, Lepri G, Rigante D, Matucci Cerinic M, Falcini F. Cross-sectional evaluation of plasma vitamin D levels in a large cohort of Italian patients with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Child Adolesc Psychopharmacol. 2018;28:124–129.
   PubMed Web of Science ®Google Scholar
• Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156(4):356–361.
   PubMedGoogle Scholar
• Prato A, Gulisano M, Scerbo M, Barone R, Vicario CM, Rizzo R. Diagnostic approach to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): a narrative review of literature data. Front Pediatr. 2021;9:746639.
   PubMed Web of Science ®Google Scholar
• Leckman JF, King RA, Gilbert DL, et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry. 2011;50(2):108–118.e3.
   PubMed Web of Science ®Google Scholar
• Bernstein GA, Victor AM, Pipal AJ, Williams KA. Comparison of clinical characteristics of paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2010;20:333–340.
   PubMed Web of Science ®Google Scholar
• Morris-Berry CM, Pollard M, Gao S, Thompson C, Singer HS. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: single-point and longitudinal assessments. J Neuroimmunol. 2013;264(1–2):106–113.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Lewin AB, Parker-Athill EC, Storch EA, Mutch PJ. Tonsillectomies and adenoidectomies do not prevent the onset of paediatric autoimmune neuropsychiatric disorder associated with group A streptococcus. Paediatr Infect Dis J. 2013;32:834–838.
   PubMed Web of Science ®Google Scholar
• Orefici G, Cardona F, Cox CJ, Cunningham MW. Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS). In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City: University of Oklahoma Health Sciences Center; 2016.
   Google Scholar
• Bryńska A, Wolańczyk T. Popaciorkowcowe autoimmunologiczne zaburzenia neuropsychiatryczne u dzieci (PANDAS). Opis 2 przypadków [Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). A report of two cases]. Psychiatr Pol. 2004;38(1):105–123. Polish.
   PubMedGoogle Scholar
• Murphy TK, Gerardi DM, Leckman JF. Paediatric acute-onset neuropsychiatric syndrome. Psychiatr Clin North Am. 2014;37:353–374.
   PubMed Web of Science ®Google Scholar
• Hansen N, Luedecke D, Malchow B, et al. Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry. J Neural Transm. 2021;128(6):735–747.
   PubMed Web of Science ®Google Scholar
• Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-haemolytic streptococcal infection increase risk for behavioural and neuropsychiatric symptoms in children? Arch Pediatr Adoles Med. 2004;158:848–856.
   PubMedGoogle Scholar
• Esposito S, Bianchini S, Baggi E, Fattizzo M, Rigante D. Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections: An overview. Eur J Clin Microbiol Infect Dis. 2014;33:1205–1209.
   Web of Science ®Google Scholar
• Gromark C, Hesselmark E, Djupedal IG, et al. A two-to-five year follow-up of a pediatric acute-onset neuropsychiatric syndrome cohort. Child Psychiatry Hum Dev. 2022;53(2):354–364.
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 2014;33:314–329.
   PubMed Web of Science ®Google Scholar
• Singer HS, Mascaro-Blanco A, Alvarez K, et al. Neuronal antibody biomarker for Sydenham’s chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection. PLoS One. 2015;10:e0120499.
   PubMed Web of Science ®Google Scholar
• Singer HS. Autoantibody-associated movement disorders in children: proven and proposed. Semin Pediatr Neurol. 2017;24(3):168–179.
   PubMed Web of Science ®Google Scholar
• Gilbert DL. Inflammation in Tic Disorders and Obsessive-Compulsive Disorder: Are PANS and PANDAS a Path Forward? J Child Neurol. 2019;34(10):598–611.
   PubMed Web of Science ®Google Scholar
• Sokol MS, Ward PE, Tamiya H, Kondo DG, Houston D, Zabriskie JB. D8/17 expression on B lymphocytes in anorexia nervosa. Am J Psychiatry. 2002;159:1430–1432.
   PubMed Web of Science ®Google Scholar
• Rodríguez N, Morer A, González-Navarro E, et al. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation. 2017;14(1):261.
   PubMedGoogle Scholar
• Parker-Athill EC, Ehrhart J, Tan J, Murphy TK. Cytokine correlations in youth with tic disorders. J Child Adolesc Psychopharmacol. 2015;25(1):86–92.
   PubMed Web of Science ®Google Scholar
• Chan A, Karpel H, Spartz E, et al. Hypoferritinemia and iron deficiency in youth with paediatric acute-onset neuropsychiatric syndrome. Paediatr Res. 2021;89:1477–1484.
   PubMed Web of Science ®Google Scholar
• Çelik G, Ta D, Tahiroglu A, Avci A, Yüksel B, Çam P. Vitamin D deficiency in obsessive-compulsive disorder patients with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: a case control study. Noro Psikiyatr Ars. 2016;53:33–37.
   PubMedGoogle Scholar
• Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children’s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844–852.
   PubMed Web of Science ®Google Scholar
• Leckman JF. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566–573.
   PubMed Web of Science ®Google Scholar
• The Research Units on Pediatric Psychopharmacology Anxiety Study Group. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002;41(9):1061–1069.
   PubMed Web of Science ®Google Scholar
• Shaffer D. A children’s global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228–1231.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Maia DP, Cardoso F. UFMG Sydenham’s chorea rating scale (USCRS): reliability and consistency. Mov Disord. 2005;20(5):585–591.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: PsychCorp; 2003.
   Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale. 4th ed. San Antonio TX: Pearson; 2008.
   Google Scholar
• Weiss LG, Saklofske DH, Coalson D, et al. WAIS-IV Clinical Use and Interpretation: Scientist-Practitioner Perspectives. Academic Press; 2010.
   Google Scholar
• Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Fourth Edition (WPPSI-IV). San Antonio, TX: Pearson USA; 2012.
   Google Scholar
• Ben-Pazi H, Stoner JA, Cunningham MW. Dopamine receptor autoantibodies correlate with symptoms in Sydenham’s chorea. PLoS One. 2013;8(9):e73516.
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiologica. 2016;216(1):90–100.
   PubMed Web of Science ®Google Scholar
• Melamed I, Kobayashi RH, O’Connor M, et al. Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol. 2021;31(2):118–128.
   PubMed Web of Science ®Google Scholar
• Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354(9185):1153–1158.
   PubMed Web of Science ®Google Scholar